Bicara Therapeutics
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $273M
Investors
- 16
About Bicara Therapeutics
Based in Massachusetts, US, and founded in 2020, Bicara Therapeutics Inc. is a clinical-stage firm that is developing biologics that combine targeted therapy with tumor modulators. As of March 2023, Claire Mazumdar serves as the CEO of the company. In December 2023, Bicara Therapeutics Inc. The company provides pipeline programs, including BCA101 and BCA356. BCA101 is a bifunctional antibody that is beneficial against a variety of tumor types, including head and neck tumors. The firm's dual-action antibodies combine tumor-targeting antibodies' precision with tumor-microenvironment (TME) modulators' capability for a significant impact at the tumor's site. Bicara uses its platform to build bifunctional molecules to target the tumor and deliver the tumor-modulating payload while reducing side effects.
Who invested in Bicara Therapeutics
16 investors across 2 rounds
See all investors in Bicara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bicara Therapeutics
Who invested in Bicara Therapeutics?
Bicara Therapeutics has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bicara Therapeutics raised?
Bicara Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bicara Therapeutics last raise money?
Bicara Therapeutics's most recent round on record is a Series C, in Dec 2023.
What does Bicara Therapeutics do?
Based in Massachusetts, US, and founded in 2020, Bicara Therapeutics Inc.
Where is Bicara Therapeutics headquartered?
Bicara Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Bicara Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bicara Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Bicara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.